VITARA BIOMEDICAL, INC. — Form D/A
VITARA BIOMEDICAL, INC. of PHILADELPHIA, PA, a company, filed a Form D amendment with the SEC on 2022-08-02. The offering totals $75.0M, of which $25.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-08-02
- Form: D/A
- Accession: 0001811355-22-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $75.0M
- Amount sold: $25.0M
- Remaining: $50.0M
- Minimum investment: $99K
- Investors: 9
- Date of first sale: 2022-07-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-454119
Issuer
- Name: VITARA BIOMEDICAL, INC.
- CIK: 0001811355
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2301 Chestnut Street, PHILADELPHIA, PA, 19103
- Phone: 267-518-6300
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| IAN RATCLIFFE | Director | Cambridge, MA |
| John Kelly | Executive Officer | New York, NY |
| Thomas Todorow | Director | Philadelphia, PA |
| Manish Kothari | Director | Philadelphia, PA |
| Bernard Lyons | Director | Philadelphia, PA |
| Bernard Lyons | Executive Officer | Philadelphia, PA |
| Diem Nguyen | Director | Philadelphia, PA |
| Ted Fjallman | Director | Philadelphia, PA |
| Rosaleen Oskanian | Executive Officer | Philadelphia, PA |
| James McGlone | Director | Philadelphia, PA |
| James McGlone | Executive Officer | Philadelphia, PA |
| Monash Kothari | Director | Philadelphia, PA |
| Arthur Dantchik | Director | PHILADELPHIA, PA |
| Jeffrey Kahn | Executive Officer | PHILADELPHIA, PA |
| Nelson Hill | Director | PHILADELPHIA, PA |
Other filings by this issuer (5)
More